92 related articles for article (PubMed ID: 3497222)
21. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.
Bukreyev A; Serra ME; Laham FR; Melendi GA; Kleeberger SR; Collins PL; Polack FP
J Virol; 2006 Jun; 80(12):5854-61. PubMed ID: 16731924
[TBL] [Abstract][Full Text] [Related]
22. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
[TBL] [Abstract][Full Text] [Related]
23. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
Johnson TR; Graham BS
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
[TBL] [Abstract][Full Text] [Related]
24. HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.
Brandenburg AH; de Waal L; Timmerman HH; Hoogerhout P; de Swart RL; Osterhaus AD
J Virol; 2000 Nov; 74(21):10240-4. PubMed ID: 11024156
[TBL] [Abstract][Full Text] [Related]
25. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
Johnstone C; Guil S; Rico MA; García-Barreno B; López D; Melero JA; Del Val M
J Gen Virol; 2008 Sep; 89(Pt 9):2194-2203. PubMed ID: 18753229
[TBL] [Abstract][Full Text] [Related]
26. DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.
Durant LR; Pereira C; Boakye A; Makris S; Kausar F; Goritzka M; Johansson C
Eur J Immunol; 2014 Aug; 44(8):2340-8. PubMed ID: 24777856
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
Haynes LM; Caidi H; Radu GU; Miao C; Harcourt JL; Tripp RA; Anderson LJ
J Infect Dis; 2009 Aug; 200(3):439-47. PubMed ID: 19545210
[TBL] [Abstract][Full Text] [Related]
28. Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
Schepens B; Ibañez LI; De Baets S; Hultberg A; Bogaert P; De Bleser P; Vervalle F; Verrips T; Melero J; Vandevelde W; Vanlandschoot P; Saelens X
J Infect Dis; 2011 Dec; 204(11):1692-701. PubMed ID: 21998474
[TBL] [Abstract][Full Text] [Related]
29. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies.
Taylor G; Stott EJ; Furze J; Ford J; Sopp P
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403
[TBL] [Abstract][Full Text] [Related]
30. Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse.
Bangham CR
Immunology; 1986 Sep; 59(1):37-41. PubMed ID: 3489669
[TBL] [Abstract][Full Text] [Related]
31. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
Ostler T; Ehl S
Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
[TBL] [Abstract][Full Text] [Related]
33. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
Chiba Y; Higashidate Y; Suga K; Honjo K; Tsutsumi H; Ogra PL
J Med Virol; 1989 Jul; 28(3):133-9. PubMed ID: 2666570
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T-cell response to respiratory syncytial virus in mice.
Bangham CR; Cannon MJ; Karzon DT; Askonas BA
J Virol; 1985 Oct; 56(1):55-9. PubMed ID: 2411951
[TBL] [Abstract][Full Text] [Related]
35. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.
Cherrie AH; Anderson K; Wertz GW; Openshaw PJ
J Virol; 1992 Apr; 66(4):2102-10. PubMed ID: 1548754
[TBL] [Abstract][Full Text] [Related]
36. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.
Muñoz JL; McCarthy CA; Clark ME; Hall CB
J Virol; 1991 Aug; 65(8):4494-7. PubMed ID: 2072460
[TBL] [Abstract][Full Text] [Related]
37. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.
Bangham CR; McMichael AJ
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9183-7. PubMed ID: 3097646
[TBL] [Abstract][Full Text] [Related]
38. Comparison of caprine, human and bovine strains of respiratory syncytial virus.
Trudel M; Nadon F; Simard C; Bélanger F; Alain R; Séguin C; Lussier G
Arch Virol; 1989; 107(1-2):141-9. PubMed ID: 2803001
[TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model.
Fuentes S; Klenow L; Golding H; Khurana S
Sci Rep; 2017 Feb; 7():42428. PubMed ID: 28186208
[TBL] [Abstract][Full Text] [Related]
40. Determining the breadth of the respiratory syncytial virus-specific T cell response.
McDermott DS; Knudson CJ; Varga SM
J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
